Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 9 | 2024 | 1841 | 0.970 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2023 | 475 | 0.910 |
Why?
|
| T-Lymphocytes | 9 | 2024 | 3947 | 0.900 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2023 | 1136 | 0.880 |
Why?
|
| Gangliosides | 1 | 2024 | 97 | 0.870 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2023 | 6987 | 0.800 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2023 | 382 | 0.700 |
Why?
|
| Virus Diseases | 1 | 2023 | 392 | 0.650 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 74 | 0.650 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2024 | 550 | 0.650 |
Why?
|
| DNA Virus Infections | 1 | 2017 | 27 | 0.590 |
Why?
|
| DNA Viruses | 1 | 2017 | 45 | 0.580 |
Why?
|
| Adoptive Transfer | 1 | 2019 | 436 | 0.570 |
Why?
|
| Transplant Recipients | 1 | 2019 | 337 | 0.550 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 493 | 0.540 |
Why?
|
| CD28 Antigens | 1 | 2017 | 204 | 0.540 |
Why?
|
| CD3 Complex | 1 | 2017 | 321 | 0.540 |
Why?
|
| Tissue Donors | 1 | 2019 | 812 | 0.490 |
Why?
|
| Herpesvirus 4, Human | 5 | 2023 | 954 | 0.490 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 595 | 0.460 |
Why?
|
| Interleukin-7 | 3 | 2023 | 93 | 0.340 |
Why?
|
| Transplantation Conditioning | 5 | 2023 | 2359 | 0.300 |
Why?
|
| Graft vs Host Disease | 3 | 2023 | 2804 | 0.280 |
Why?
|
| Transplantation, Homologous | 5 | 2023 | 3036 | 0.280 |
Why?
|
| Alemtuzumab | 3 | 2023 | 208 | 0.250 |
Why?
|
| Lymphoma | 2 | 2024 | 1514 | 0.250 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2024 | 25 | 0.240 |
Why?
|
| Child | 14 | 2024 | 30559 | 0.240 |
Why?
|
| Leukemia | 2 | 2024 | 1721 | 0.230 |
Why?
|
| beta-Thalassemia | 1 | 2023 | 33 | 0.230 |
Why?
|
| Neoplasms, Second Primary | 1 | 2012 | 1388 | 0.230 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 1488 | 0.220 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2019 | 683 | 0.220 |
Why?
|
| Child, Preschool | 10 | 2024 | 17056 | 0.220 |
Why?
|
| Neuroblastoma | 3 | 2019 | 703 | 0.220 |
Why?
|
| CD27 Ligand | 1 | 2021 | 26 | 0.190 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 60 | 0.190 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 372 | 0.170 |
Why?
|
| Adolescent | 12 | 2024 | 32730 | 0.170 |
Why?
|
| Tissue Banks | 1 | 2019 | 51 | 0.170 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2019 | 2903 | 0.170 |
Why?
|
| Neoplasm Grading | 1 | 2024 | 1827 | 0.170 |
Why?
|
| Infant | 5 | 2024 | 13970 | 0.160 |
Why?
|
| Neoplasms | 2 | 2022 | 15930 | 0.160 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 25 | 0.150 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 103 | 0.150 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2018 | 73 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 369 | 0.140 |
Why?
|
| Humans | 25 | 2024 | 272087 | 0.140 |
Why?
|
| Adenoviruses, Human | 1 | 2017 | 191 | 0.140 |
Why?
|
| Herpesvirus 6, Human | 1 | 2017 | 81 | 0.140 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 192 | 0.140 |
Why?
|
| Young Adult | 6 | 2024 | 22142 | 0.140 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 163 | 0.140 |
Why?
|
| HLA Antigens | 1 | 2019 | 588 | 0.140 |
Why?
|
| BK Virus | 1 | 2017 | 126 | 0.140 |
Why?
|
| Antigens, CD19 | 1 | 2019 | 584 | 0.130 |
Why?
|
| Interleukin-15 | 1 | 2017 | 189 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2023 | 1255 | 0.130 |
Why?
|
| Adult | 12 | 2024 | 81933 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 487 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2019 | 1668 | 0.130 |
Why?
|
| Cerebroside-Sulfatase | 1 | 1994 | 8 | 0.120 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 433 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2021 | 7258 | 0.110 |
Why?
|
| Interleukin-2 | 1 | 2017 | 891 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 967 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2019 | 1068 | 0.110 |
Why?
|
| Glioma | 1 | 2024 | 1988 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1732 | 0.100 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 936 | 0.100 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 1728 | 0.100 |
Why?
|
| Leukocytes | 1 | 1994 | 426 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 1020 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 802 | 0.100 |
Why?
|
| Male | 10 | 2024 | 129088 | 0.090 |
Why?
|
| Mice | 6 | 2023 | 36053 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2017 | 3078 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 1950 | 0.090 |
Why?
|
| Female | 11 | 2024 | 149288 | 0.090 |
Why?
|
| Age of Onset | 1 | 2012 | 855 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 16612 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3363 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 3929 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 15279 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2022 | 3546 | 0.080 |
Why?
|
| Unrelated Donors | 2 | 2021 | 321 | 0.070 |
Why?
|
| Animals | 6 | 2023 | 62822 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 718 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2017 | 1781 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2017 | 4195 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2019 | 33909 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2024 | 39831 | 0.060 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3026 | 0.060 |
Why?
|
| Radiotherapy Dosage | 1 | 2012 | 4003 | 0.060 |
Why?
|
| Lymphocyte Depletion | 1 | 2024 | 311 | 0.050 |
Why?
|
| Recurrence | 2 | 2022 | 4887 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 14881 | 0.050 |
Why?
|
| Cytokines | 2 | 2023 | 2841 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 55 | 0.050 |
Why?
|
| Aged | 6 | 2024 | 73517 | 0.050 |
Why?
|
| Neutropenia | 1 | 2024 | 1001 | 0.040 |
Why?
|
| Risk Factors | 2 | 2017 | 18051 | 0.040 |
Why?
|
| Middle Aged | 6 | 2024 | 90460 | 0.040 |
Why?
|
| Busulfan | 1 | 2023 | 786 | 0.040 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2019 | 58 | 0.040 |
Why?
|
| Retroviridae | 1 | 2019 | 376 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2024 | 872 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 345 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2001 | 372 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 65 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 37 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 493 | 0.040 |
Why?
|
| Chemokines | 1 | 2019 | 296 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 119 | 0.040 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2017 | 94 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 1470 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 190 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 183 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 1057 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2018 | 422 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 277 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 684 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 3231 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 408 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2017 | 7302 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2019 | 1514 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2019 | 1887 | 0.030 |
Why?
|
| Lysosomes | 1 | 1994 | 346 | 0.020 |
Why?
|
| Vaccination | 1 | 2017 | 1156 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1590 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 1113 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 6440 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 3690 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 13410 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 5864 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10259 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8612 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 12534 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 7476 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 9101 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 738 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 996 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 12223 | 0.010 |
Why?
|
| Monocytes | 1 | 2001 | 789 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 31066 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 1429 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1994 | 10750 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 6911 | 0.010 |
Why?
|